SARS-CoV-2 Vaccine Development: Is a Finish Line in Sight?

Register now for this exclusive, extended webinar discussing the latest developments in the journey towards COVID-19 vaccines – for both Australia and the world.

  • Gain an understanding of the current COVID-19 vaccine development landscape, clinical trials and next steps in vaccine deployment.
  • Hear an overview of and update on the Oxford Vaccine Group–Astra Zeneca ChAdOx1 nCoV-19 vaccine development from Professor Andrew Pollard.
  • Learn about the Coalition for Epidemic Preparedness Innovation (CEPI)’s COVAX response to COVID-19 from Dr Melanie Saville.
  • Hear about where we are now in Australia and internationally and realistic expectations for the next 6–12 months.
  • Consider the ethical and logistical implications of global vaccine implementation, specifically approaches for the Indo-Pacific region.

There will be opportunity for questions and discussion.


  • Professor Kristine Macartney, Director, NCIRS
  • Professor Andrew Pollard, Professor of Paediatric Infection and Immunity, Oxford Vaccine Group, University of Oxford
  • Dr Melanie Saville, Director of Vaccine Research & Development, Coalition for Epidemic Preparedness Innovations

Discussion panel (speakers will be joined by):

  • Professor Paul Kelly, Acting Chief Medical Officer, Australian Government Department of Health
  • Dr Stephanie Williams, Australian Ambassador for Regional Health Security, Department of Foreign Affairs and Trade
  • Associate Professor Christopher Blyth, Co-Chair, Australian Technical Advisory Group on Immunisation




Venue: Webinar

Date/Time: Part day | Mon 23 Nov 2020, 7:00 pm - 8:30 pm (1.5hrs) AEDT

Event Organiser: National Centre for Immunisation Research and Surveillance (NCIRS)

Contact: Salema Barrett

Phone: (02) 9845 1433

Email: Click here